BRIEF-Pacific Edge Says Novitas Fails To Consider New Peer Reviewed Evidence Supporting Use Of CXbladder, Others

Reuters

13 Jan

BRIEF-Pacific Edge Says Novitas Fails To Consider New Peer Reviewed Evidence Supporting Use Of CXbladder, Others

Jan 13 (Reuters) - Pacific Edge Ltd PEB.NZ:

NOVITAS FAILS TO CONSIDER NEW PEER REVIEWED EVIDENCE SUPPORTING USE OF CXBLADDER, OTHERS
NOW ACTIVATING CONTINGENCY PLANS AND STRATEGIES TO FURTHER REDUCE OUR EXPENSE BASE UNTIL WE REGAIN RELIABLE MEDICARE COVERAGE
WELL PLACED TO FUND RE-COVERAGE PROCESS IF NECESSARY AND REGAIN REIMBURSEMENT FOR OUR TESTS

Further company coverage: PEB.NZ

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2503190263"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2503190263\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2503190263?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-13 09:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2503190263","market":"us","top_or_hot":-1,"title":"BRIEF-Pacific Edge Says Novitas Fails To Consider New Peer Reviewed Evidence Supporting Use Of CXbladder, Others","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Pacific Edge Says Novitas Fails To Consider New Peer Reviewed Evidence Supporting Use Of CXbladder, Others</title></head><body><p><span>Jan 13 (Reuters)</span><span> - </span>Pacific Edge Ltd <span>PEB.NZ</span>:</p><ul><li><p>NOVITAS FAILS TO CONSIDER NEW PEER REVIEWED EVIDENCE SUPPORTING USE OF CXBLADDER, OTHERS</p></li><li><p>NOW ACTIVATING CONTINGENCY PLANS AND STRATEGIES TO FURTHER REDUCE OUR EXPENSE BASE UNTIL WE REGAIN RELIABLE MEDICARE COVERAGE</p></li><li><p>WELL PLACED TO FUND RE-COVERAGE PROCESS IF NECESSARY AND REGAIN REIMBURSEMENT FOR OUR TESTS</p></li></ul><p>Further company coverage: <span>PEB.NZ</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Pacific Edge Says Novitas Fails To Consider New Peer Reviewed Evidence Supporting Use Of CXbladder, Others</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Pacific Edge Says Novitas Fails To Consider New Peer Reviewed Evidence Supporting Use Of CXbladder, Others\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-01-13 09:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Pacific Edge Says Novitas Fails To Consider New Peer Reviewed Evidence Supporting Use Of CXbladder, Others</title></head><body><p><span>Jan 13 (Reuters)</span><span> - </span>Pacific Edge Ltd <span>PEB.NZ</span>:</p><ul><li><p>NOVITAS FAILS TO CONSIDER NEW PEER REVIEWED EVIDENCE SUPPORTING USE OF CXBLADDER, OTHERS</p></li><li><p>NOW ACTIVATING CONTINGENCY PLANS AND STRATEGIES TO FURTHER REDUCE OUR EXPENSE BASE UNTIL WE REGAIN RELIABLE MEDICARE COVERAGE</p></li><li><p>WELL PLACED TO FUND RE-COVERAGE PROCESS IF NECESSARY AND REGAIN REIMBURSEMENT FOR OUR TESTS</p></li></ul><p>Further company coverage: <span>PEB.NZ</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PEB","symbol_name":"Pebblebrook Hotel Trust","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O60UD:1","article_id":"2503190263","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2503190263","pubTimestamp":1736731389,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Pacific Edge Says Novitas Fails To Consider New Peer Reviewed Evidence Supporting Use Of CXbladder, OthersJan 13  - Pacific Edge Ltd PEB.NZ:NOVITAS FAILS TO CONSIDER NEW PEER REVIEWED EVIDENCE SUPPORTING USE OF CXBLADDER, OTHERSNOW ACTIVATING CONTINGENCY PLANS AND STRATEGIES TO FURTHER REDUCE OUR EXPENSE BASE UNTIL WE REGAIN RELIABLE MEDICARE COVERAGEWELL PLACED TO FUND RE-COVERAGE PROCESS IF NECESSARY AND REGAIN REIMBURSEMENT FOR OUR TESTSFurther company coverage: PEB.NZ ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PEB":"Pebblebrook Hotel Trust","BK4218":"酒店及度假村房地产信托","BK4181":"酒店及度假村房地产投资信托"},"translate_title":"简介-Pacific Edge表示Novitas未能考虑支持使用CXbladder等的新同行评审证据","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PEB":0.9},"content_text":"BRIEF-Pacific Edge Says Novitas Fails To Consider New Peer Reviewed Evidence Supporting Use Of CXbladder, OthersJan 13 (Reuters) - Pacific Edge Ltd PEB.NZ:NOVITAS FAILS TO CONSIDER NEW PEER REVIEWED EVIDENCE SUPPORTING USE OF CXBLADDER, OTHERSNOW ACTIVATING CONTINGENCY PLANS AND STRATEGIES TO FURTHER REDUCE OUR EXPENSE BASE UNTIL WE REGAIN RELIABLE MEDICARE COVERAGEWELL PLACED TO FUND RE-COVERAGE PROCESS IF NECESSARY AND REGAIN REIMBURSEMENT FOR OUR TESTSFurther company coverage: PEB.NZ ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}